A Randomized, Open-Label, Parallel Two-Arm Study Evaluating the Efficacy of H.P. Acthar Injection Gel in the Treatment of Adults With Intractable Chronic Migraine
Phase of Trial: Phase II
Latest Information Update: 21 Apr 2016
At a glance
- Drugs Corticotropin (Primary)
- Indications Migraine
- Focus Therapeutic Use
- 21 Apr 2016 Status changed from active, no longer recruiting to completed, according to results presented at the 68th Annual Meeting of the American Academy of Neurology.
- 21 Apr 2016 Results (n=30) presented at the 68th Annual Meeting of the American Academy of Neurology.
- 19 Aug 2014 Planned primary completion date changed from 1 Apr 2014 to 1 Dec 2014 as reported by ClinicalTrials.gov.